LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $386,000 | +70.8% | 3,074 | +84.6% | 0.01% | +75.0% |
| Q4 2018 | $226,000 | -65.3% | 1,665 | -29.9% | 0.00% | -66.7% |
| Q3 2018 | $652,000 | +18.3% | 2,375 | -10.7% | 0.01% | +9.1% |
| Q2 2018 | $551,000 | +25.2% | 2,661 | -0.0% | 0.01% | +22.2% |
| Q1 2018 | $440,000 | +21.5% | 2,662 | +0.6% | 0.01% | +12.5% |
| Q4 2017 | $362,000 | -2.4% | 2,647 | -3.0% | 0.01% | +14.3% |
| Q3 2017 | $371,000 | +172.8% | 2,730 | +142.2% | 0.01% | +133.3% |
| Q2 2017 | $136,000 | +11.5% | 1,127 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $122,000 | -27.4% | 1,153 | -31.0% | 0.00% | -25.0% |
| Q4 2016 | $168,000 | -3.4% | 1,670 | -3.0% | 0.00% | 0.0% |
| Q3 2016 | $174,000 | -13.0% | 1,722 | +2.4% | 0.00% | -33.3% |
| Q2 2016 | $200,000 | – | 1,682 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |